Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rapid genotyping of porcine reproductive and respiratory syndrome virus (PRRSV) using MinION nanopore sequencing. | PLoS One | 2023 | 37220122 | PubTator, text mining | PubMed |
| Which strain of the avian coronavirus vaccine will become the prevalent one in China next? | Front Vet Sci | 2023 | 37215473 | PubTator, text mining | PubMed |
| A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice. | Front Immunol | 2023 | 37205110 | PubTator, text mining | PubMed |
| In vitro evidence against productive SARS-CoV-2 infection of human testicular cells: Bystander effects of infection mediate testicular injury. | PLoS Pathog | 2023 | 37200377 | PubTator, text mining | PubMed |
| SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery. | Microbiol Spectr | 2023 | 37199631 | PubTator, text mining | PubMed |
| A review of current effective COVID-19 testing methods and quality control. | Arch Microbiol | 2023 | 37195393 | PubTator, text mining | PubMed |
| Different electrostatic forces drive the binding kinetics of SARS-CoV, SARS-CoV-2 and MERS-CoV Envelope proteins with the PDZ2 domain of ZO1. | Sci Rep | 2023 | 37193746 | PubTator, text mining | PubMed |
| Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics. | Bioimpacts | 2023 | 37193075 | PubTator, text mining | PubMed |
| Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era. | Biomedicines | 2023 | 37189833 | PubTator, text mining | PubMed |
| Regulation of Epithelial Sodium Transport by SARS-CoV-2 Is Closely Related with Fibrinolytic System-Associated Proteins. | Biomolecules | 2023 | 37189326 | PubTator, text mining | PubMed |
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| Drug repurposing approach against chikungunya virus: an in vitro and in silico study. | Front Cell Infect Microbiol | 2023 | 37180434 | PubTator, text mining | PubMed |
| From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID. | Int J Mol Sci | 2023 | 37175995 | PubTator, text mining | PubMed |
| TLRs: Innate Immune Sentries against SARS-CoV-2 Infection. | Int J Mol Sci | 2023 | 37175768 | PubTator, text mining | PubMed |
| Viral Vector-Based Gene Therapy. | Int J Mol Sci | 2023 | 37175441 | PubTator, text mining | PubMed |
| Persistent and fatal severe acute respiratory syndrome coronavirus 2 infection in a patient with severe hypogammaglobulinemia: a case report. | J Med Case Rep | 2023 | 37173711 | PubTator, text mining | PubMed |
| A review of the antiviral activity of cationic antimicrobial peptides. | Peptides | 2023 | 37172781 | PubTator, text mining | PubMed |
| Predictive potential of SARS-CoV-2 RNA concentration in wastewater to assess the dynamics of COVID-19 clinical outcomes and infections. | Sci Total Environ | 2023 | 37164095 | PubTator, text mining | PubMed |
| Interactome-Based Machine Learning Predicts Potential Therapeutics for COVID-19. | ACS Omega | 2023 | 37163139 | PubTator, text mining | PubMed |
| SARS-CoV-2 envelope protein triggers depression-like behaviors and dysosmia via TLR2-mediated neuroinflammation in mice. | J Neuroinflammation | 2023 | 37158916 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=23